XTX Topco’s IO Biotech IOBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-265,792
| Closed | -$15.6K | – | 4413 |
|
|
2026
Q1 | $15.6K | Buy |
265,792
+249,928
| +1,575% | +$85.3K | ﹤0.01% | 3608 |
|
|
2025
Q4 | $9.66K | Sell |
15,864
-163,343
| -91% | -$121K | ﹤0.01% | 3186 |
|
|
2025
Q3 | $65.1K | Buy |
179,207
+150,018
| +514% | +$259K | ﹤0.01% | 2112 |
|
|
2025
Q2 | $40.6K | Sell |
29,189
-21,297
| -42% | -$24.4K | ﹤0.01% | 2056 |
|
|
2025
Q1 | $55K | Buy |
50,486
+22,446
| +80% | +$21.2K | ﹤0.01% | 1986 |
|
|
2024
Q4 | $25.8K | Buy |
+28,040
| New | +$27.9K | ﹤0.01% | 2002 |
|
|
2024
Q3 | – | Sell |
-26,555
| Closed | -$31.1K | – | 2325 |
|
|
2024
Q2 | $31.1K | Buy |
26,555
+10,688
| +67% | +$14.9K | ﹤0.01% | 1563 |
|
|
2024
Q1 | $27.8K | Buy |
+15,867
| New | +$27.6K | ﹤0.01% | 1567 |
|
|
2023
Q4 | – | Sell |
-21,238
| Closed | -$29.3K | – | 1829 |
|
|
2023
Q3 | $29.3K | Buy |
+21,238
| New | +$37.3K | 0.01% | 1338 |
|
XTX Topco's IOBT Position: Q2 2026 in Review
XTX Topco sold out of IO Biotech (IOBT) in Q2 2026, closing a stake of 265,792 shares — an estimated $15.6K sold.
XTX Topco first reported a position in IOBT in Q3 2023 and held it in 9 quarters. The position peaked at $65.1K in Q3 2025. 0 funds tracked by Wall St. Rank hold IOBT as of Q2 2026.
- XTX Topco reported no remaining IO Biotech position as of Q2 2026 after selling out during the quarter.
- XTX Topco sold 265,792 IO Biotech shares in Q2 2026, an estimated $15.6K.
- XTX Topco first reported a position in IO Biotech in Q3 2023 and held it in 9 quarters.
- XTX Topco's IO Biotech position peaked at $65.1K in Q3 2025.
- 0 funds tracked by Wall St. Rank held IO Biotech as of Q2 2026.
Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.